MicroRNA modulation of lipid metabolism and oxidative stress in cardiometabolic diseases.
about
Subclinical Detection of Diabetic Cardiomyopathy with MicroRNAs: Challenges and PerspectivesRNA binding protein HuR regulates the expression of ABCA1.MicroRNA-185 regulates expression of lipid metabolism genes and improves insulin sensitivity in mice with non-alcoholic fatty liver disease.MicroRNAs in bovine adipogenesis: genomic context, expression and functionTargeting metabolic disorders by natural products.Micro-RNAs and macrophage diversity in atherosclerosis: new players, new challenges…new opportunities for therapeutic intervention?'Atherothrombosis-associated microRNAs in Antiphospholipid syndrome and Systemic Lupus Erythematosus patients'miR-31 Links Lipid Metabolism and Cell Apoptosis in Bacteria-Challenged Apostichopus japonicus via Targeting CTRP9.High-density lipoprotein, beta cells, and diabetes .Harnessing the Therapeutic Potential of MicroRNAs for Cardiovascular Disease.Lipid metabolism, apoptosis and cancer therapy.MicroRNA-138 Regulates DNA Damage Response in Small Cell Lung Cancer Cells by Directly Targeting H2AX.Epigenetic regulation in monocyte/macrophage: A key player during atherosclerosis.Coenzyme Q10 increases cholesterol efflux and inhibits atherosclerosis through microRNAs.Posttranscriptional control of airway inflammation.Sunflower oil supplementation affects the expression of miR-20a-5p and miR-142-5p in the lactating bovine mammary gland.Micromanaging Glucose Tolerance and Diabetes.Inhibition of miR-155 attenuates abdominal aortic aneurysm in mice by regulating macrophage-mediated inflammation.Role of MicroRNAs in Obesity-Induced Metabolic Disorder and Immune Response.Maternal high-fat diet consumption modulates hepatic lipid metabolism and microRNA-122 (miR-122) and microRNA-370 (miR-370) expression in offspring.
P2860
Q26771750-6942F938-5BFC-469A-B098-EAFD0B726D54Q33653613-A1DE14C0-A6E5-40EC-BA89-1FA02418347FQ34750679-5DC227CF-863A-40C9-9AAF-96D828316F2EQ35096642-066AF370-E814-4010-B559-31D950C1BB76Q35830892-C52308EF-348F-4503-99A0-C932673727E2Q36125865-69616927-BE20-4589-9846-92A7A76BDB56Q37159985-9415C650-6212-44F1-9D62-E88FC0022A37Q37694420-E1E80171-CF71-4C3E-BB46-8038776A9198Q38218039-1FBBAF18-4D11-4EE1-9F3B-3F2829E1E1C3Q38254809-02EDDE81-4C56-4A86-8B41-CBFEC86E3CD7Q38308411-D63A8898-2AEC-4513-BBF3-68CC06C3A10CQ38907837-F730CF7C-3EF1-4D32-8630-BC46C4EC301FQ39216733-C9F155C6-684D-4AEB-8F34-D96A65C4D1BCQ42154417-9D518DA8-4E26-4A50-A845-7BC756556CECQ47601835-02E514E5-2C54-4EE2-9063-6B7BE82D6CBDQ48342382-0A42CBE7-572E-4C1E-B642-86CC49FD0C3BQ49332519-EC73F61F-D4DE-4ED3-89AE-022AC0F4B648Q49832618-EB046562-7208-494F-B6E5-EC94E62938E6Q50316940-FB0AB7B2-7375-4149-8AC0-50D92BC4865DQ50675151-60FC17B2-11D1-4229-82F1-B84BCA379620
P2860
MicroRNA modulation of lipid metabolism and oxidative stress in cardiometabolic diseases.
description
2013 nî lūn-bûn
@nan
2013 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
MicroRNA modulation of lipid metabolism and oxidative stress in cardiometabolic diseases.
@ast
MicroRNA modulation of lipid metabolism and oxidative stress in cardiometabolic diseases.
@en
MicroRNA modulation of lipid metabolism and oxidative stress in cardiometabolic diseases.
@nl
type
label
MicroRNA modulation of lipid metabolism and oxidative stress in cardiometabolic diseases.
@ast
MicroRNA modulation of lipid metabolism and oxidative stress in cardiometabolic diseases.
@en
MicroRNA modulation of lipid metabolism and oxidative stress in cardiometabolic diseases.
@nl
prefLabel
MicroRNA modulation of lipid metabolism and oxidative stress in cardiometabolic diseases.
@ast
MicroRNA modulation of lipid metabolism and oxidative stress in cardiometabolic diseases.
@en
MicroRNA modulation of lipid metabolism and oxidative stress in cardiometabolic diseases.
@nl
P2860
P50
P1476
MicroRNA modulation of lipid metabolism and oxidative stress in cardiometabolic diseases
@en
P2093
Carlos Fernández-Hernando
P2860
P356
10.1016/J.FREERADBIOMED.2013.07.014
P577
2013-07-17T00:00:00Z